Long-term survival after dose-dense high-dose chemotherapy with progenitor cell support as primary treatment for patients with advanced ovarian cancer

被引：0
|
作者：
Eisenhauer, E. L. [1 ]
Tew, W. P. [1 ]
Sabbatini, P. J. [1 ]
Spriggs, D. R. [1 ]
Chi, D. S. [1 ]
Barakat, R. R. [1 ]
Aghajanian, C. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
GYNECOLOGIC ONCOLOGY | 2008年 / 108卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
90
引用
收藏
页码：S41 / S42
页数：2
相关论文
共 50 条
  • [41] Long-Term Survival after High-Dose Chemotherapy Followed by Peripheral Stem Cell Rescue for High-Risk, Locally Advanced/Inflammatory, and Metastatic Breast Cancer
    VanderWalde, A.
    Ye, W.
    Frankel, P.
    Asuncion, D.
    Leong, L.
    Luu, T.
    Morgan, R.
    Twardowski, P.
    Koczywas, M.
    Pezner, R.
    Paz, I. B.
    Margolin, K.
    Wong, J.
    Doroshow, J. H.
    Forman, S.
    Shibata, S.
    Somlo, G.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (08) : 1273 - 1280
  • [42] Long-term survival after high-dose chemotherapy followed by peripheral stem cell rescue for high-risk locally advanced/inflammatory and metastatic breast cancer
    Vanderwalde, A. M.
    Ye, W.
    Frankel, P. H.
    Asuncion, D. G.
    Pezner, R. D.
    Luu, T. H.
    Shibata, S.
    Leong, L. A.
    Margolin, K. A.
    Morgan, R.
    Koczywas, M.
    Chow, W. A.
    Twardowski, P.
    Wong, J. Y.
    Doroshow, J. H.
    Forman, S. J.
    Somlo, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [43] High-dose therapy with peripheral blood progenitor cell support (PBPC) for the treatment of advanced breast cancer
    Fersis, N
    Haas, R
    Wallwiener, D
    Hohaus, S
    Huober, J
    Bastert, G
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 661 - 661
  • [44] HIGH-DOSE CISPLATIN CARBOPLATIN CHEMOTHERAPY IN PRIMARY ADVANCED EPITHELIAL OVARIAN-CANCER
    FANNING, J
    HILGERS, RD
    GYNECOLOGIC ONCOLOGY, 1993, 51 (02) : 182 - 186
  • [45] Long-term Significance (15 years) of Pathological Complete Response after Dose-dense Neoadjuvant Chemotherapy in Breast Cancer
    Wang-Lopez, Qian
    Abrial, Catherine
    Planchat, Eloise
    Mouret-Reynier, Marie-Ange
    Cure, Herve
    Gimbergues, Pierre
    Dubray-Longeras, Pascale
    Gadea, Emilie
    Kwiatkowski, Fabrice
    Penault-Llorca, Frederique
    Chollet, Philippe
    Durando, Xavier
    BREAST JOURNAL, 2013, 19 (04): : 448 - 450
  • [46] High-dose therapy with peripheral blood progenitor cell support (PBPC) for the treatment of advanced breast cancer
    Fersis, N
    Haas, R
    Wallwiener, D
    Hohaus, S
    Fruhauf, S
    Bastert, G
    BREAST, 1997, 6 (05): : 321 - 321
  • [47] High-dose chemotherapy with autologous hematopoietic progenitor cell support for metastatic and high-risk primary breast cancer
    Bearman, SI
    Shpall, EJ
    Jones, RB
    Cagnoni, PJ
    Ross, M
    SEMINARS IN ONCOLOGY, 1996, 23 (01) : 60 - 67
  • [48] Long Term Survival After High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation in Metastatic Breast Cancer.
    Hamilton, Betty K.
    Bolwell, Brian J.
    Rybicki, Lisa
    Tench, Shawnda
    Kalaycio, Matt
    Andresen, Steven
    Dean, Robert M.
    Sobecks, Ronald
    Pohlman, Brad
    Hill, Brian T.
    Hanna, Rabi
    Duong, Hien K.
    Copelan, Edward A.
    BLOOD, 2012, 120 (21)
  • [49] Bevacizumab with dose-dense paclitaxel/carboplatin as first-line chemotherapy for advanced ovarian cancer
    Zhang, Li
    Zhou, Qi
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 837 : 64 - 71
  • [50] Dose-dense and dose-intense chemotherapy for small cell ovarian cancer: 2 cases and review of literature
    Raj Kumar Shrimali
    Peter Denzil Correa
    Nick S. Reed
    Medical Oncology, 2011, 28 : 766 - 770
12345